Trial · NCT03972488
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression Free Survival (PFS) Per Central Assessment | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | 22.8 | 95% Confidence Interval 19.4 to NA | months | |
| Progression Free Survival (PFS) Per Central Assessment | Octreotide LAR 60 mg (Control Arm) | 8.5 | 95% Confidence Interval 7.7 to 13.8 | months | |
| Overall Response Rate (ORR) Per Central Assessment (Key Secondary) | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | 43.0 | 95% Confidence Interval 35.0 to 51.3 | Percentage of participants | |
| Overall Response Rate (ORR) Per Central Assessment (Key Secondary) | Octreotide LAR 60 mg (Control Arm) | 9.3 | 95% Confidence Interval 3.8 to 18.3 | Percentage of participants | |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | Global Health status | 13.2 | 95% Confidence Interval 8.8 to 17.2 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Octreotide LAR 60 mg (Control Arm) | Global Health status | 8.6 | 95% Confidence Interval 5.8 to 14.0 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | Diarrhea | 17.4 | 95% Confidence Interval 14.4 to 28.2 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Octreotide LAR 60 mg (Control Arm) | Diarrhea | 17.3 | 95% Confidence Interval 8.1 to NA | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | Fatigue | 6.0 | 95% Confidence Interval 3.4 to 6.8 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Octreotide LAR 60 mg (Control Arm) | Fatigue | 6.0 | 95% Confidence Interval 3.9 to 11.0 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | Pain | 10.3 | 95% Confidence Interval 6.0 to 13.6 | months |
| Time to Deteriration (TTD) Global Health Status, Diarrhea, Fatigue, Pain (EORTC QLQ-C30) (Key Secondary) | Octreotide LAR 60 mg (Control Arm) | Pain | 8.6 | 95% Confidence Interval 3.9 to 13.7 | months |
| Disease Control Rate (DCR) Per Central Assessment | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | 90.7 | 95% Confidence Interval 84.9 to 94.8 | Percentage of participants | |
| Disease Control Rate (DCR) Per Central Assessment | Octreotide LAR 60 mg (Control Arm) | 66.7 | 95% Confidence Interval 54.8 to 77.1 | Percentage of participants | |
| Duration of Response (DOR) Per Central Assessment | Lutathera® Plus Octreotide LAR 30 mg (Investigational Arm) | 23.3 | 95% Confidence Interval 18.4 to NA | months | |
| Duration of Response (DOR) Per Central Assessment | Octreotide LAR 60 mg (Control Arm) | NA | 95% Confidence Interval NA to NA | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03972488/results